Clinical Trial Update: Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria [Phase 4]

View source ↗

Summary

Phase 4 trial update examining renal effects of empagliflozin alone or with semaglutide in people with type 2 diabetes and albuminuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Type 2 Diabetes with Renal Manifestations

Drugs mentioned

• Empagliflozin (empagliflozin)
• semaglutide (semaglutide)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Type 2 Diabetes With Renal Manifestations | Phase 4 | Status: UNKNOWN